The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.124.12.1640

Measurements of rheumatoid factor were done on the sera of 86 patients consecutively admitted to an acute psychiatric service. Sixty-three percent of those with endogenous depressions and 35 percent of those with schizophrenia had positive titers. When the schizophrenic patients were subdivided on the basis of affective state, it was found that 65 percent of those with depressive symptoms, and only 21 percent of those without depressive symptoms, had positive titers. The authors conclude that depression would seem to be associated with a nonspecific effect involving immunological mechanisms.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.